Gaucher spleen sphingolipid activator protein 2 was fractionated into concanavalin A binding-and nonbinding fractions. These fractions each contained several bands on non-denaturing polyacrylamide gel electrophoresis (PAGE). The two fractions were further fractionated by electroblotting the proteins from preparative gels onto nitrocellulose, staining with Ponceau S to locate the bands of protein and then eluting the protein components from the nitrocellulose. A total of ten fractions, each containing only one or two major components, was collected. All of these subfractions activated ,l-glucocerebrosidase and sphingomyelinase and most subfractions also activated ,-galactocerebrosidase. The structural relationship of the bands was investigated using endoglycosidase digestions. The results indicated that the two bands with the fastest mobility on non-denaturing PAGE did not contain any carbohydrate. The remaining bands showed only limited or partial digestion with endoglycosidase H and endoglycosidase D, but were readily hydrolysed with endoglycosidase F. The products of these digestions included bands with similar mobilities to the non-carbohydrate containing bands.
INTRODUCTION
An activator protein for ,8-glucocerebrosidase was first isolated from a patient with Gaucher's disease type I (Ho & O'Brien, 1971) . Since then, similar preparations [variously referred to as factor P, Gaucher factor/ activator, heat stable factor, sphingolipid activator protein 2 (SAP-2), co-,f-glucosidase and cohydrolase sphingolipid-1] have been isolated from normal human spleen tissue (Peters et al., 1977) , bovine spleen (Berent & Radin, 1981a) and control and Gaucher's disease brain . In addition, immunologically cross-reacting material has been identified in mouse brain and liver (Datta & Radin, 1986) and human skin fibroblasts (Fujibayashi & Wenger, 1985; Ranieri et al., 1986) . The activator activates sphingomyelinase and ,-galactocerebrosidase in addition to ,1-glucocerebrosidase Poulos et al., 1984a) . In the case of ,J-glucocerebrosidase, the activator has been shown to bind to the enzyme (Ho, 1975; Berent & Radin, 1981b; Aerts et al., 1987) and there is also a requirement for acidic phospholipids (Ho & Rigby, 1975; Berent & Radin, 1981b; Prence et al., 1985; Basu et al., 1985; Prence et al., 1986) . Activation of ,?-galacetocerebrosidase by the activator also requires acidic phospholipids .
The various activator preparations have been shown to consist of a group of low molecular mass acidic glycoproteins. Iyer et al. (1983) noted four major bands in their preparations after non-denaturing gel electrophoresis and staining with Stains-All. Using a more sensitive immunological staining procedure, we were able to detect many more bands in a similar preparation from Gaucher spleen (Ranieri et al., 1986) . Multiple bands of immunologically cross-reacting material have also been detected in skin fibroblasts (Fujibayashi & Wenger, 1985; Ranieri et al., 1986) . Some differences in the mobility of the activator components between control human, Gaucher and bovine spleen activator preparations (Iyer et al., 1983) and also between human skin fibroblasts and Gaucher spleen activator (Ranieri et al., 1986 ) have been noted. Christomanou & Kleinschmidt (1985) and Christomanou et al. (1986) also reported heterogeneity in their low molecular mass activator preparation for sphingomyelinase. However, their activator components, while showing many similarities, also differ in some respects from the activator preparations already mentioned and may represent a different class of activator proteins. An apparently distinct fl-glucocerebrosidase activator has also been isolated from human placenta (Vaccaro et al., 1985) . In addition, apolipoprotein C III, which is present as two low molecular mass components, stimulates sphingomyelin hydrolysis (Alpert & Beaudet, 1981; Ahmad et al., 1986) .
In 1980, it was proposed that Niemann-Pick disease type C resulted from a deficiency in an activator for ,-glucocerebrosidase (Christomanou, 1980) . However, neither Fujibayashi & Wenger (1985) nor our own laboratory (Ranieri et al., 1986) severely affected type A patients does not respond to activator, while the residual activity in Niemann-Pick types B and C is responsive to the activator (Poulos et al., 1984b) . In addition, the activator is induced in mouse tissues after injecting mice with a fl-glucocerebrosidase inhibitor or with glucocerebroside, galactocerebroside, or sphingomyelin (Datta & Radin, 1986) .
In this paper we examine the multiple activator components present in Gaucher spleen extract. We were interested to know whether the heterogeneity of the preparation could be attributed to differences in carbohydrate content and/or whether the individual components have any specificity towards the three different sphingolipid hydrolases.
MATERIALS AND METHODS

Materials
The DEAE-cellulose anion exchanger (DE 52) was from Whatman Ltd. (Maidstone, Kent, U.K.) and the Fractogel TSK HW 55S from Merck (Darmstadt, Germany). Acrylamide, NN'-methylenebisacrylamide, NNN'N'-tetramethylethylenediamine, ammonium persulphate, 4-chloro-1-naphthol, Bio-Gel HPHT hydroxylapatite column with hydrophilic guard column and the Bio-Gel phenyl-5PW hydrophobic interaction column were obtained from Bio-Rad Laboratories (Richmond, CA, U.S.A.). Pharmacia (Uppsala, Sweden) supplied the Mono Q HR 5/5 anion exchange column. Schleicher und Schull (Dassel, Germany) provided the 0.1,um pore nitrocellulose membrane and the Vectastain ABC kit, biotinylated lectin kits I and II, and the agarose-bound Ricinus communis agglutinin I (RCA120) (4 mg/ml packed gel) and Pisum sativum agglutinin (PSA) (3 mg/ ml packed gel) were from Vector Laboratories (Burlingame, CA, U.S.A.). (Poulos et al., 1984a) , using a modification of the method of Peters et al. (1977 (v/v) was then treated with trichloroacetic acid (Peters et al., 1977) and the resulting soluble fraction applied to a DEAEcellulose DE 52 anion exchange column (Poulos et al., 1984a) . The activator was eluted with a NaCl gradient. After this step the activator was either fractionated or further purification of the total preparation was achieved using a Fractogel TSK HW 55S gel filtration column followed by preparative polyacryamide gel electrophoresis (PAGE) (Ranieri et al., 1986) . During purification the activator was monitored by activation of fibroblast sphingomyelinase activity. The activator was stored in silanized glassware at -20°C for all steps after the trichloroacetic acid precipitation.
When stained for the presence of protein, with either Coomassie Blue R250 or silver, the post-preparative PAGE-purified SAP-2 contains only two closely-migrating, diffusely-staining bands after either SDS or urea/ SDS/PAGE (Ranieri et al., 1986 ). On a non-denaturing gel, only two diffuse bands are visualized with Coomassie Blue R250, but with Stains-All four major bands are visible (Ranieri et al., 1986) . Three of the Stains-All staining bands correspond to the slower migrating Coomassie staining band. Additional bands, within the region corresponding to protein staining on the original gel, are detected if the gel is electroblotted and immunostained. Activator activity is associated with all of the protein staining region of a non-denaturing gel of SAP-2 (Ranieri et al., 1986) . Separation of activator components A portion (13 mg of protein) of the DE 52 column purified activator was first separated into Con A bindingand non-binding fractions using a 2.5 cm x 2.5 cm Con A-Sepharose 4B column. Unbound components were eluted with 50 ml of 20 mM-Tris/HCl/0.5 M-NaCl buffer, pH 7.0, while bound fractions were eluted with 50 ml of the same buffer containing 0.5 M-methyl a-D-mannopyranoside. The fractions were extensively dialysed against water, freeze-dried and redissolved in 10 mmTris/HCl, pH 7.0. Aliquots (5) of each fraction were applied independently to non-denaturing polyacrylamide gels. The gels were prepared as described previously (Ranieri et al., 1986) , but with 15 % (w/v) acrylamide in the resolving gel and 4% (w/v) acrylamide in the stacking gel. After electrophoresis, the protein bands were transferred to 0.1 sm pore nitrocellulose by electroblotting (Burnette, 1981) for 60 min at 0.2 A. The nitrocellulose was then stained for 10 min with Ponceau S (Salinovich & Montelaro, 1986) , rinsed with water to remove background staining and then strips, corresponding to bands of activator, were removed by cutting the nitrocellulose. Where possible individual bands were separated, but, in the slower mobility region, it was not possible to discern individual components. The strips were cut into pieces and placed in silanized vials and rinsed with 10 ml of water with intermittent shaking for several minutes. The water was replaced with a fresh pH 8.9, with gentle shaking for 3 h (Parekh et al., 1985) . The samples were collected with a further 0.5 ml rinse and centrifuged (15 000 g for 5 min) in an Eppendorf 5413 centrifuge to remove any particulate nitrocellulose. The samples were then freeze-dried and dissolved in 100 ,1 of 10 mM-Tris/HCl buffer, pH 7.0. To remove residual nitrocellulose and Ponceau S, the samples were then run on a high pressure 100 mm x 7.8 mm Bio-Gel HPHT hydroxylapatite column with a 50 mm x 4.0 mm hydrophilic guard column. The column was equilibrated with 10 mM-NaH2PO4/0.3 mM-CaCl2, pH 6.8, buffer. The sample was injected and the column washed for a few minutes with the same buffer and then with a linear 0-100 % gradient of 0.3 M-NaH2PO4/0.0l mM-CaCl2, pH 6.8 buffer. Residual nitrocellulose and Ponceau S eluted at low phosphate concentrations, while the activator components eluted at high phosphate concentrations. The presence of activator components was confirmed by immunoblotting. The relevant fractions were then pooled, dialysed extensively against water, freeze-dried and dissolved in water.
Other chromatographic procedures
The lectin binding studies indicated that some of the activator components bind to Con A, RCA120 and PSA. The Con A column chromatography is described above.
For the RCA120-agarose column, the equilibration buffer was 20 mM-Tris/HCI. 0.15 M-NaCl, pH 7.0 and the activator was eluted with the same buffer containing 0.5 M-methyl /-D-galactopyranoside. With the PSAagarose column, the same equilibration buffer was used and the elution buffer contained 0.5 M-methyl a-Dmannopyranoside.
As the activator protein contains a hydrophobic region, aliquots of the total activator were applied to an h.p.l.c. phenyl-5PW hydrophobic interaction column. The column was equilibrated with a 1.7 M-(NH4)2SO4, 0.1 M-NaH2PO4 buffer, pH 7.0. After injection, the activator was eluted with a linear gradient of decreasing (NH4)2SO4 concentration.
Total activator, or Con A bound and unbound fractions, were also applied to a high performance Mono Q anion exchange column, to see if this column gave better resolution than the low pressure DE 52 anion exchanger. The starting buffer was 20 mM-Tris/HCl, pH 7.5 and elution was with a gradient of the same buffer containing 0.3 M-NaCl.
Protein assays
The protein content of activator samples was determined by the Lowry method (Lowry et al., 1951) or, where greater sensitivity was required, by Sargent's modification of this procedure (Sargent, 1987) . For the fibroblast extracts used in the enzyme assays, protein was determined by the method of Bradford (1976) . In each case human albumin was used as the standard. Immunostaining
Immunostaining of spots of activator or of electroblotted gels was performed as previously described (Ranieri et al., 1986 ) using the sensitive Vectastain ABC kit method which utilizes a biotinylated goat anti-(rabbit IgG) serum and an avidin bridge to biotinylated horseradish peroxidase. The primary antibody was raised in rabbits (Ranieri et al., 1986 ) using 0.4 mg of post-preparative PAGE-purified activator for the primary injection and 0.1 mg of activator protein for the booster injection 10 weeks later. Lectin staining Nitrocellulose-bound Gaucher SAP-2, either spots or from electroblotted gels, was stained using biotinylated lectins (Vector kits I and II) in combination with the ABC reagent from the Vectastain ABC kit (as used for immunostaining). Although highly purified gelatin or bovine serum albumin was used for the blocking solution, problems with background staining occurred with a few of these lectins. It should be noted that approx. 20-fold more protein was required for lectin staining than for immunostaining.
The lectin staining kits contained the following biotinylated lectins: Con A, soybean agglutinin, wheat germ agglutinin, Dolichos biflorus agglutinin, Ulex europaeus agglutinin I, RCA120, peanut agglutinin, Bandeiraea simplicifolia lectin I, PSA, Lens culinaris agglutinin, Phaseolus vulgaris erythroagglutinin, Phaseolus vulgaris leucoagglutinin, Sophora japonica agglutinin and succinylated wheat germ agglutinin.
Analysis of activator components by PAGE
Activator protein fractions were analysed on nondenaturing Triton polyacryamide gels. These gels were prepared as described for the preparative gels, but included 0.2% (w/v) Triton X-100 in the stacking gel, resolving gel and reservoir buffer. The samples were applied to the wells in 0.1 M-Tris/HCl, pH 6.8, 10%
(w/v) sucrose, 0.2% (w/v) Triton X-100 and 0.02% (w/v) Bromophenol Blue. After electrophoresis, the gels were electroblotted onto nitrocellulose and then immunostained.
Endoglycosidase digestions
Aliquots of activator fractions were digested with various endoglycosidases as indicated. For Endo D digestions, the buffer was 25 mM-NaH2PO4, pH 6.5 and 5 munits of Endo D was added per assay. For Endo F digestions, the buffer was 25 mM-NaH2PO4/2.5 mm-EDTA, pH 6.1 and 0.5 units of Endo F was used per assay. For Endo H digestions, the buffer was 25 mmNaH2PO4, pH 5.5, and 6 munits of Endo H was added to each incubation. In some preliminary studies, Con Abound and unbound fractions were digested with N-glycanase. The buffer for these incubations was 10 mmNaH2PO4/0.1 mM-EDTA, pH 8.6, and 0.3 units of Nglycanase was used per assay tube. In each case the incubations also contained Triton X-100 at a final concentration of 0.6% (w/v), and the final incubation volume was 30,1. The assays were set up in sealed microfuge tubes and incubated at 37°C for 24 h (72 h for the earlier studies with N-glycanase). Units of activity for the endoglycosidases were as defined by the suppliers.
Sphingolipid hydrolase assays
Normal human skin fibroblast cell lines were used as a source of sphingomyelinase, 8-glucocerebrosidase and /,-galactocerebrosidase. The cells were cultured as described (Ranieri et al., 1986) , harvested by trypsinization and resuspended in 0.25 M-sucrose. The cells were then disrupted by repeated freeze-thawing and sonication.
The substrates for the enzyme assays were added in the liposomal form (Poulos et al., 1983) with 10,1 of the appropriate liposomal substrate added to each assay in a Vol. 254 (Suzuki & Suzuki, 1972) . The assays contained 50 mM-acetate buffer, pH 4.5, and the incubations were for 2 h at 37 'C. All three assays were terminated as previously described and the radioactivity in the aqueous phase determined (Poulos et al., 1984a) .
RESULTS
Separation of activator components
Our preparative PAGE-purified Gaucher SAP-2 preparation had previously been shown to contain a number immunoreactive components on non-denaturing polyacrylamide gels. As the antibody used for the staining was polyclonal, we were interested to check if all the components had activator activity. A number ofchromatography procedures were used to attempt to separate the bands. We were already aware that the preparation could be divided into Con A binding-and non-binding fractions (Ranieri et al., 1986) . Likewise, separation into binding-and non-binding fractions could also be attained on PSA and RCA120 lectin columns. A combination of Con A and RCA120 chromatography gave some additional separation, but the recoveries were low (results not shown). Only partial separation of the activator components was obtained with an h.p.l.c. anion exchange column (results not shown), while all the bands co-eluted from either an h.p.l.c-hydrophobic interaction column or an h.p.l.c.-hydroxylapatite column (results not shown).
As several bands could be identified on polyacrylamide gels, we opted to cut out bands of activator protein after electroblotting the gels onto nitrocellulose and staining with Ponceau S. Because of the considerable number of upper bands, prior separation into Con A binding-and non-binding fractions was beneficial. After eluting the bands from the nitrocellulose, contaminants were re-moved by h.p.l.c-hydroxylapatite column chromatography and dialysis. The final extracts were dissolved in 40,1 of water and 2,1 of each was then applied to analytical gels (Fig. 1) . It was not possible to estimate recovery of activator protein in the fractions because the Con A bound and unbound material applied to the gels contains contaminating Con A (the Con A leeches from the column in spite of extensive washing and the use of a high salt buffer). The Con A is separated from the activator components during electrophoresis, so is not present in the final activator fractions.
Activation of sphingolipid hydrolase
The ten fractions of Gaucher activator were tested for activation of ,J-glucocerebrosidase, sphingomyelinase and /8-galactocerebrosidase (Table 1) . The fraction numbers are as designated in Fig. 1 . Two concentrations
(1 1ul and 3 ,ul) of each fraction were tested against each enzyme, but only results for 3 #u1 are shown. All the fractions activated fl-glucocerebrosidase and sphingomyelinase and most fractions stimulated fl-galactocerebrosidase. The lack of response of fl-galactocerebrosidase activity to fractions 1 and 2, and the only slight response to fractions 3, 4 and 5, may result from using nonoptimal concentrations of these fractions. Unfortunately, there was not enough material to test an extensive range of concentrations. The results indicate that individual fractions do not have specific activator activity towards a single hydrolase. It was not possible to estimate the per cent recovery of activator activity in the different fractions, because the activity of the activator is not linearly related to the amount of activator added. In addition, the response to each activator preparation varies with the batch of fibroblasts used in the assays.
Endoglycosidase digestions Each activator fraction was digested with Endo D, F and H. Blank incubations of the endoglycosidase enzymes, without added activator fractions, did not produce any cross-reacting material to Gaucher SAP-2 (results not shown). In addition, activator proteins incubated without any endoglycosidase enzymes remained unchanged (results not shown). It should be noted that a different set of isolated fractions were used for these studies than in Fig. 1 . Slight differences in recovery and banding pattern were found between different batches of fractions, particularly for those fractions with slower mobility on PAGE. This arose because of the poorer resolution of the bands and the diffuseness of Ponceau S staining for bands in this region. The actual fractions used for the incubations are indicated (Fig. 2 and 3) . Fractions 1 and 2 showed no change after digestion with the three endoglycosidases (Fig. 2a) , indicating that they did not contain any Nlinked oligosaccharide. This observation was supported by lectin staining studies. Neither of these fractions stained with any of the 14 lectins tested (results not shown). The remaining eight fractions showed only limited or partial hydrolysis with Endo D and Endo H (Fig. 2 and 3) , presumably because of lack of appropriate specificity or because of the presence of blocking terminal sugar residues. In general the Con A-binding fractions were more susceptible to Endo D and H than the Con Anon-binding fractions. In contrast, all eight fractions were readily digested with Endo F (Fig. 2 and 3 ).
On digestion with endoglycosidase, bands with mobility similar to either fraction 1 and/or 2 were produced. Where bands similar to both 1 and 2 (that is with digests of fractions 4, 5, 6, 8 and 9) were produced from the one fraction, this was probably accounted for by heterogeneity in the original sample. In some instances the mobility of the resulting band(s) was a little slower than either fraction 1 (as with fraction 3) and/or 2 (as with fractions 4, 5 and 6), or there was heterogeneous staining in the region of either fraction 1 and/or 2 (as with fractions 7, 8 and 9). This may result from heterogeneity in the starting fractions. However, it might also be caused by the presence of small amounts of contaminating enzymes in the endoglycosidase preparations. When Endo D, F and H cleave an oligosaccharide(s) from glycoproteins, an N-acetylglucosamine residue(s) remains linked to the asparagine residue(s) on the protein.
Since the molecular mass of the activator components is quite low [3000-6500 by urea/SDS/PAGE (Ranieri et al., 1986) ], the presence of a sugar residue on the peptides may noticeably retard their mobility. However, the presence of small contaminating amounts of N-acetylglucosaminidase in the Endo D and H preparations, or of N-glycanase in the Endo F, may remove the sugar from some or all of these molecules to yield products with the same mobility as either fraction 1 or 2. Interestingly, in earlier studies using N-glycanase digestions of Con A-unbound and bound fractions, the products ran in line with fraction 1 and/or 2 (results not shown). Unlike Endo D, F and H, N-glycanase removes all of the oligosaccharide from the protein. Un- fortunately, the cost of this enzyme prevented more extensive investigation.
Where digestion of the fractions with Endo F did occur, bands running ahead of fraction I were observed on the gels. The identity of this material is not known, but it may represent the oligosaccharides released from the glycopeptides. Similar bands had also been seen with the N-glycanase digestions. The faster moving of these bands appeared to be generated when a product with mobility similar to fraction 1 was formed (digests of fraction 3, 4, 5, 6, 7 and 8) , while the slower moving of these bands was associated with digestions which yielded fraction 2-like material (digests of fraction 4, 5, 6 and 10). It would have been interesting to compare the lectin staining of activator components before and after endoglycosidase digestion. However, the relatively low sensitivity of the lectin staining compared to immunostaining would not allow detection of the small amounts of activator used for the endoglycosidase digestions.
DISCUSSION
Our Gaucher SAP-2 preparation was separated into ten fractions, all of which had activator activity. In addition, there did not appear to be any specificity of any fraction towards a single sphingolipid hydrolase. Two of the fractions appeared to be non-glycosylated, implying that carbohydrate is not required for activator activity. Endoglycosidase digestions indicated that the other glycosylated components are probably related to one or other of these peptides. We are currently investigating whether or not the two non-glycosylated peptides are Fig. 2(a) . 4 result from processing of terminal sugars on core oligosaccharides. After treatment with Endo F, bands with faster mobility than the non-glycosylated peptides were produced. We presume these are the oligosaccharides which have been removed from the glycopeptides, as the antigenicity of oligosaccharides is well documented (Feizi & Childs, 1987) . Preliminary evidence indicates that there are probably only two major oligosaccharide products, but clearly the staining pattern would depend on whether all the possible oligosaccharide variations are recognized by our polyclonal antiserum, whether or not the different released oligosaccharides co-migrate on electrophoresis, and to what extent each oligosaccharide binds to the nitrocellulose. Results with fraction 1 and 2 clearly indicate that our polyclonal antibody also recognizes the peptide structure(s) of the Gaucher SAP-2 components. In theory, some indication of an oligosaccharide's structure can be deduced from its affinity to different lectins and its susceptibility to hydrolysis by certain endoglycosidases. However, in the present case the overall pattern was too confusing to draw any firm conclusions. Fujibayashi & Wenger (1986) demonstrated that the SAP-2 is first synthesized as 68000 and 73000 Da forms and is then processed to 12000 and 9000 Da forms (molecular mass estimated by SDS/PAGE). In our earlier studies using SDS/PAGE (Poulos et al., 1984a) , we found that our activator migrated in a similar molecular mass region to the processed forms, but a lower molecular mass range (3000-6500) was estimated by urea/SDS/PAGE. Similar lower molecular masses were obtained on urea/SDS gels by Berent & Radin (1981a) for bovine spleen activator and also by Christomanou & Kleinschmidt (1985) for their activator preparation. (Of course, it should be noted that the glyscosylation of the activator components may affect the relationship between molecular mass and mobility of the bands on SDS and urea/SDS gels.) Fujibayashi & Wenger (1986) showed that their 9000 molecular mass form could be deglycosylated with Endo F to give a 7600 Da form. Better resolution of activator components is found on non-denaturing gels (Iyer et al., 1983 : Ranieri et al., 1986 , and, when immunostaining is used, additional components are detected. Thus, we were able to detect more lower molecular mass components than Fujibayashi & Wenger (1986) . Presumably their 7600 Da form corresponds to one or other or both of our nonglycosylated activator components.
Our results indicate that, if an SAP-2 deficiency disease state does exist, patients would be expected to accumulate fl-glucocerebroside, sphingomyelin and /,-galactocerebroside in their tissues. In addition, the hydrolysis of the cytotoxic compound galactosylsphingosine (psychosine) is carried out by fl-galactocerebrosidase and this hydrolase activity is also stimulated by the same activator (Goda et al., 1987 
